Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin in Acute Ischemic Stroke
NCT01863277Phase 4Unknown
- Sponsor
- Edith Wolfson Medical Center
- Start
- Jul 2013
- Primary completion
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in ischemic stroke comparing Melatonin with Placebo (2 arms). Primary endpoint: Modified Rankin Scale at 3 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT01863277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01863277.